Lifetime excess body weight and significant weight gain in adulthood are associated with an increased risk for renal cell ...

A new urine-based biomarker test could cut in half the need for surveillance imaging to detect recurrence of the most common ...

PD-32766 for patients with clear cell renal cell carcinoma (ccRCC) was conducted at the National Cancer Center Hospital East and promising results were obtained. PET positive rate: 64 Cu-PD-32766 was ...

The AUR87A study found that urine collected biomarkers could accurately predict recurrence of kidney cancer in post-surgery ...

ICI-based combinations are the preferred first-line therapy due to their proven superiority over TKI monotherapy, many patients were not receiving them,” the researchers wrote.

Urine glycosaminoglycan profiles (GAGomes) have high sensitivity for nonmetastatic clear-cell renal cell carcinoma (M0ccRCC) ...

The company presented its results this week at a conference and anticipates that with additional validation early next year, it will be ready to file for regulatory approval.

Excess weight in mid-life is a known risk factor for kidney cancer, but new research indicates that weight patterns throughout life may also affect an individual's likelihood of developing this ...

Dr. Emre Yekedüz discusses his top 3 key takeaways from attending the 2025 ASCO Genitourinary (GU) Cancers Symposium.

Fruzaqla given in combination with sintilimab slowed progression in the second line for those with locally advanced or metastatic renal cell carcinoma.

Hutchmed China, alongside Innovent Biologics, announced on Wednesday that the FRUSICA-2 phase two and three clinical trial ...